ZFPM1 rs4782371: Understanding This Genetic Variant

What each genotype means

What is rs4782371?

The rs4782371 variant is a specific change in the human DNA sequence, categorized as a single-nucleotide polymorphism (SNP). It is located on chromosome 16 at position 88,502,423 (GRCh38). This variant sits within an intronic region of the ZFPM1 gene, which stands for zinc finger protein, FOG family member 1. Because it is located in an intron—a non-coding region of the gene—it does not directly alter the protein sequence of the ZFPM1 gene product. Instead, researchers study such variants to understand how they might influence gene expression or regulatory processes. In the context of genomic studies, rs4782371 has been identified through genome-wide association studies (GWAS) as a marker of interest for its statistical link to specific physiological traits, particularly those related to vascular biology.

The Role of the ZFPM1 Gene

The ZFPM1 gene encodes a protein known as FOG-1 (Friend of GATA 1). This protein acts as a transcriptional regulator, meaning it helps control the activity of other genes by binding to specific DNA sequences. FOG-1 is well-documented for its essential role in hematopoiesis, the process by which the body produces blood cells. Specifically, it is involved in the formation of platelets and the differentiation of red blood cells. By acting as part of a transcriptional repressor complex, ZFPM1 helps ensure that blood cell development proceeds correctly. Because of its influence on these fundamental biological processes, variations in or near this gene are often investigated for their potential to affect systemic factors, such as the levels of signaling proteins circulating in the blood.

Research Associations and Evidence Strength

The primary association for rs4782371 is with circulating levels of vascular endothelial growth factor (VEGF). VEGF is a critical signaling protein that stimulates the growth of new blood vessels, a process known as angiogenesis. A large-scale meta-analysis of genome-wide association studies identified rs4782371 as a significant locus for VEGF levels, with a reported p-value of 1.59 x 10^-9. While this statistical association is robust within the context of the study, the evidence strength for this variant's clinical impact remains limited. The biological mechanism linking this intronic variant to VEGF levels is thought to involve the regulation of platelet biogenesis and functionality, as many genes in the associated loci are involved in these pathways. It is important to note that while these associations are statistically significant in research settings, they do not currently provide a basis for clinical diagnosis or individual health predictions.

Population Frequency

The rs4782371 variant is considered a common SNP across various human populations. Large-scale genomic databases, such as gnomAD and the 1000 Genomes Project, indicate that both the G and T alleles are present at significant frequencies globally. This commonality is typical for variants identified in GWAS, as these studies are often designed to detect common genetic markers that contribute to phenotypic variation across the general population. Because the variant is widespread, it is likely that a large portion of the population carries at least one copy of the minor allele. Researchers use this frequency data to ensure that their findings are representative and to better understand the distribution of genetic diversity across different ancestral backgrounds.

Interpreting Your Genetic Information

If you have encountered rs4782371 in a personal genetic report, it is important to understand that this information is primarily for educational and research purposes. The association between this variant and VEGF levels is a population-level observation, not a diagnostic tool for individual health. Genetic variants often interact with environmental factors, lifestyle, and other genes to influence a person's biology. You cannot use this information to determine your risk for specific diseases or to guide medical decisions. If you have concerns about your cardiovascular health or any other medical condition, you should consult with a qualified healthcare professional. They can provide personalized guidance based on your clinical history, physical examinations, and validated diagnostic tests, rather than relying on individual genetic markers.

Frequently asked questions

Sources & further reading